1. Home
  2. SHFS vs NXTS Comparison

SHFS vs NXTS Comparison

Compare SHFS & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SHF Holdings Inc.

SHFS

SHF Holdings Inc.

N/A

Current Price

$0.15

Market Cap

2.7M

Sector

Finance

ML Signal

N/A

Logo Nexentis Technologies Inc. Common Stock

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$1.47

Market Cap

2.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SHFS
NXTS
Founded
2015
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Agricultural Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SHFS
NXTS
Price
$0.15
$1.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
292.0K
17.8K
Earning Date
04-15-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
95.30
N/A
EPS
N/A
N/A
Revenue
$7,673,532.00
$263,445.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.55
52 Week High
$9.18
$23.80

Technical Indicators

Market Signals
Indicator
SHFS
NXTS
Relative Strength Index (RSI) 32.50 30.83
Support Level N/A $0.55
Resistance Level $0.21 $2.08
Average True Range (ATR) 0.01 0.14
MACD 0.00 0.01
Stochastic Oscillator 12.72 19.48

Price Performance

Historical Comparison
SHFS
NXTS

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: